GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » C-Rad AB (OSTO:CRAD B) » Definitions » Forward PE Ratio

C-Rad AB (OSTO:CRAD B) Forward PE Ratio : 28.20 (As of Jun. 29, 2025)


View and export this data going back to 2007. Start your Free Trial

What is C-Rad AB Forward PE Ratio?

C-Rad AB's Forward PE Ratio for today is 28.20.

C-Rad AB's PE Ratio without NRI for today is 38.00.

C-Rad AB's PE Ratio (TTM) for today is 38.00.


C-Rad AB Forward PE Ratio Historical Data

The historical data trend for C-Rad AB's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C-Rad AB Forward PE Ratio Chart

C-Rad AB Annual Data
Trend 2021-12 2022-12 2023-12 2024-12
Forward PE Ratio
34.72 27.40 20.70 13.03

C-Rad AB Quarterly Data
2021-09 2021-12 2022-03 2022-06 2022-09 2022-12 2023-03 2023-06 2023-09 2023-12 2024-03 2024-06 2024-09 2024-12 2025-03
Forward PE Ratio 44.64 34.72 34.60 51.02 21.51 27.40 24.10 21.74 14.84 20.70 20.37 21.28 13.74 13.03 13.21

Competitive Comparison of C-Rad AB's Forward PE Ratio

For the Medical Devices subindustry, C-Rad AB's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C-Rad AB's Forward PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, C-Rad AB's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where C-Rad AB's Forward PE Ratio falls into.


;
;

C-Rad AB Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


C-Rad AB  (OSTO:CRAD B) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


C-Rad AB Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of C-Rad AB's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


C-Rad AB Business Description

Traded in Other Exchanges
Address
Sjukhusvagen 12K, Uppsala, SWE, 753 09
C-Rad AB is a Sweden-based company engaged in the development and sales of systems with applications in radiation therapy for the treatment of cancer. The systems can be used to position the patient before the treatment and to localize and monitor the tumor by recording information such as patient movements during radiation treatment. Its product portfolio includes the Catalyst and Sentinel systems. Geographically, the company generates a majority of its revenue from Asia Pacific region, and also has its presence in Europe, Middle East and Africa and the rest from Americas.

C-Rad AB Headlines

No Headlines